Breaking
Technology

Bioneex Appoints Dr. Sergiy Golovin as Chief Technology Officer

📅 Published: 9 Nov 2026, 11:07 pm IST• 🔄 Updated: 9 Nov 2026, 11:07 pm IST• 4 min read• 3 views
The Bioneex headquarters in Syracuse, New York, where the company develops its AI-powered pharmaceutical asset evaluation platform.
Bioneex is headquartered in Syracuse, New York, developing AI-powered tools.
Key Points
  • Bioneex appointed Dr. Sergiy Golovin as CTO on November 9, 2026.
  • Golovin previously worked as a data scientist at Amazon and holds a Ph.D. in Economics.
  • The appointment aims to enhance the platform's predictive modelling and asset matching capabilities.
  • Bioneex connects biopharma companies and investors through its AI-powered search and evaluation tools.

Bioneex, a company based in Syracuse, New York, appointed Dr. Sergiy Golovin as its Chief Technology Officer on 9 November 2026. The firm develops an AI-powered platform used to identify and evaluate pharmaceutical assets.

The appointment is intended to strengthen the company's technical leadership in the areas of therapeutic asset evaluation and AI development platform architecture.

Strengthening AI-powered therapeutic asset evaluation

Dr. The appointment is intended to strengthen the company's technical leadership in therapeutic asset evaluation and AI development platform architecture.

As CTO, Dr. Bioneex is currently developing additional AI capabilities intended for single-asset evaluation and deeper diligence.

CEO Dr. Smbat Rafayelyan on technical leadership

Dr. Smbat Rafayelyan, Founder and CEO of Bioneex, said: “This appointment strengthens Bioneex’s technical leadership as we advance our search and evaluation platform”.

Dr. Rafayelyan stated“Dr.

Dr. Golovin’s strategy for asset matching

Dr. Golovin has identified the improvement of asset matching relevance as a primary technical priority.

The strategy involves integrating owner-submitted information with curated records and predictive models.

Professional background and predictive modelling expertise

Dr. His professional experience includes developing predictive models at Amazon and creating machine learning solutions for Fortune 500 companies. He has also advised or co-founded early-stage technology startups.

His career spans work across the manufacturing, pharmaceutical, energy, media, and advertising sectors. He is a data engineer and data analyst with expertise in programming languages such as PySpark and SQL.

He uses deployment tools including GitHub, Terraform, and Jenkins alongside data analytics tools like Power BI, SQL Server, and Databricks. He manages scalable data infrastructures using cloud-based solutions such as Azure.

Career history at Accenture and other firms

Dr. Golovin holds a Bachelor's degree and a Master's degree in System Analysis from the Taras Shevchenko National University of Kyiv. His professional career began as a Media Researcher at Mindshare, where he worked from July 2019 until July 2020.

He later was a Media Analyst at the advertising holding company Megapolis from July 2020 to May 2022. Following this role, he was employed as an Azure Data Engineer at Accenture starting in May 2022.

A colleague who worked with Dr.

Vladimír Gašpar, who was a career counsellor for Dr. Golovin, said he had the opportunity to supervise his career growth from a professional and personal perspective. Mr. Gašpar noted that over the years, Dr. Golovin grew in both the data engineering and data science fields and "enhanced his soft skills thanks to his assertive".

Dr. Golovin is currently employed at VÚB banka.

Platform operations for biopharma and investors

The company connects biopharma firms and investors with drug development organisations.

Frequently Asked Questions

Who is the new CTO of Bioneex?
Dr. Sergiy Golovin, a former Amazon data scientist, was appointed CTO on November 9, 2026.
What are Dr. Golovin's technical priorities?
His priorities include improving asset matching relevance and expanding analytical capabilities for individual asset evaluation.
How this story was made: written with AI assistance from the published reports and data linked below, then checked by automated filters that compare its facts against those sources. Spotted an error? Tell us and we will correct it. Our editorial policy.

Add NewsPulse Time as a preferred source on Google

Get the week's best in one email
One digest a week: the most-read posts and the numbers worth knowing. No spam; unsubscribe in one click.
BioneexSergiy GolovinCTOAIPharmaceuticalsSyracuseTechnology
Share: